Trial Profile
Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 05 Feb 2016 New trial record